학술논문

Eculizumab, a real-life successful treatment for refractory cold agglutinin–mediated auto-immune hemolytic anemia secondary to lymphoproliferative disorders
Document Type
Letter
Source
Annals of Hematology. 100(8):2105-2106
Subject
Language
English
ISSN
0939-5555
1432-0584